Core Viewpoint - Glass House Brands Inc. is a vertically integrated cannabis company facing financial challenges despite its optimistic outlook for future production capabilities [1][6] Financial Performance - The company reported an earnings per share (EPS) of -$0.20, missing the estimated EPS of -$0.15, indicating ongoing profitability struggles [2][6] - Revenue for the company was approximately $38.86 million, falling short of the estimated $45.8 million [3][6] - The negative price-to-earnings (P/E) ratio is approximately -415.12, with a negative earnings yield of -0.24% [2] Future Projections - Glass House Brands forecasts its wholesale cannabis biomass production to reach about one million pounds in 2026, a 50% increase from 2025 [3] - The company projects its cash and restricted cash balance to exceed $50 million by the end of 2026, up from $23.4 million at the end of 2025 [4] Financial Health - The current ratio is approximately 2.24, indicating strong short-term financial health [4][6] - The debt-to-equity ratio is about 0.93, suggesting a moderate level of debt relative to equity [5] - The enterprise value to sales ratio is approximately 3.24, reflecting the company's valuation relative to its sales [5]

Toronto, ON M5X 1G5, Canada Tel: +1 (416) 862-7525 (Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices) C T Corporation System 1015 15 Street N.W., Suite 1000 Washington, D.C., 20005 Tel: +1 (866) 925-9916 (Name, address, including zip code, and telephone number, including area code, of agent for service) With copies to: Sharagim Habibi Gowling WLG(Canada) LLP 1600, 421 7 Avenue SW, Calgary Alberta, T2p 4K9, Canada Tel: +1 (403) 298-1000 Union ...

Core Insights - Village Farms International reported record profitability and cash generation in fiscal 2025, driven by significant growth in global cannabis sales and international exports, alongside contributions from its Netherlands recreational cannabis business [1][4] - The company experienced a "step function transformation" in profitability and cash flow, with global cannabis sales increasing by 70% year-over-year [4] - Near-term supply constraints and shipment timing issues have created variability in quarterly performance, but management expects capacity expansions to alleviate these constraints [2][14] Financial Performance - In the fourth quarter, net sales rose 9% year-over-year to $49.6 million, with net income from continuing operations of $2.3 million and adjusted EBITDA of $8.6 million [3][6][8] - For the full year, net income from continuing operations was reported at $21 million, with adjusted EBITDA reaching $50 million and cash flow from continuing operations at $58 million [4] - Canadian cannabis net sales for the full year increased by 12% to a record $228 million, with fourth-quarter sales growing 10% year-over-year [11] International Expansion and Capacity - International exports increased more than six-fold, contributing significantly to revenue growth [1][4] - The Delta 2 expansion in Canada is expected to add approximately 15 metric tons of production in 2025 and 40 metric tons annually by mid-2027, representing a 33% increase [17] - The Netherlands Phase II facility is nearing completion, expected to bring total annual production capacity to approximately 10 metric tons [19] Strategic Milestones - The company privatized its legacy produce business in May, allowing it to retain long-term optionality tied to its greenhouse assets [5] - Management highlighted the importance of maintaining a top-five market share position in Canada, particularly in the dried flower segment [10] Cost Structure and Tax Implications - The company incurred $21.5 million in Canadian excise taxes during the fourth quarter, which accounted for nearly 40% of retail-branded sales [13] - Canadian cannabis gross margin improved to 43% in the fourth quarter, up from 3% a year ago, driven by a higher proportion of international exports and a focus on higher-margin products [12]

Core Insights - Village Farms International reported strong financial performance for Q4 2025, achieving record levels in profitability, gross margin, and cash flow from operations, indicating a transformational year for the company [2][3]. Financial Performance - Consolidated net income from continuing operations for the full year 2025 was $21.0 million, or $0.19 per share, with adjusted EBITDA from continuing operations at $49.9 million and operating cash flow of $58.1 million [3][8]. - Q4 2025 consolidated net sales increased by 9% year-over-year to $49.6 million, with Canadian cannabis sales up 10% and international export cannabis sales soaring by 384% [3][8]. - The company ended 2025 with $86 million in cash and has completed $6.7 million in share repurchases since Q3 2025 [3][8]. Operational Highlights - The company commenced cultivation in the first half of its Delta 2 expansion in Canada, expected to yield an additional 15 tonnes of production capacity in 2026 [2][3]. - The Netherlands facility is operating at full capacity, with plans to scale operations for a Phase II facility in Groningen, anticipated to reach an annual production capacity of approximately 10 tonnes [2][3]. - International export sales increased significantly, driven by demand in Germany and other international markets, positioning the company as a leading exporter of medical cannabis to Europe [2][3]. Market Position and Strategy - Village Farms maintains a top five market share position in Canada and is the number one in dried flower as of February 2026, despite planned reductions in lower-margin SKUs [2][3]. - The company is focused on capital allocation for organic and acquisitive investments while enhancing shareholder value through ongoing share repurchases [2][3]. - New product innovations, including unique packaging solutions, have been introduced to the Canadian market, contributing to the company's competitive edge [2][3].

Core Insights - THC Therapeutics, Inc. is executing a revitalized strategy focused on growth through acquisitions in the cannabis industry, aiming to align market valuation with operational progress and long-term growth prospects [2][5][6] Corporate Highlights - The company believes its current trading price does not reflect the underlying value of its businesses and assets, primarily due to its Expert Market status [2] - THC Therapeutics plans to enhance communication with investors by hiring an experienced investor relations firm to effectively convey its value proposition and growth strategy [3] - The company is committed to optimizing its portfolio and investing in high-potential opportunities to maximize returns and create sustainable shareholder value [4] Acquisition Activity - THC Therapeutics has made transformative acquisitions, including six companies under The Headquarters Group, Inc., which positions the company for growth in the national cannabis market [5][9] - The company has filed its first 10-K since its transformation, indicating progress towards becoming fully reporting [9] - THC Therapeutics is actively exploring new acquisition opportunities while managing operations to maximize revenue [11] Portfolio Management - The company is focused on active portfolio management, optimizing its asset mix to capitalize on growth opportunities in the cannabis market [12] - THC Therapeutics operates in two states and has a healthy pipeline of potential acquisitions that complement its existing portfolio [11] Business Model - THC Therapeutics employs a vertically integrated business model that includes cultivation, manufacturing, and distribution, allowing it to buffer risks and enhance cash flow through ancillary businesses [13]

Core Viewpoint - THC Therapeutics, Inc. is executing a revitalized strategy focused on growth through strategic acquisitions in the cannabis sector, aiming to align market valuation with operational progress and long-term growth prospects [4][5][9]. Corporate Highlights - The company believes its current trading price does not reflect the underlying value of its operating businesses and assets, primarily due to its Expert Market status [5]. - THC Therapeutics has completed its first 10-K filing since its transformation, marking a significant step towards becoming fully reporting [10]. - The company has made transformative acquisitions in cannabis cultivation, distribution, manufacturing, and ancillary businesses, laying a foundation for growth in the national cannabis market [8][12]. Investor Relations and Communication - To enhance communication with the investment community, the company plans to hire an experienced investor relations firm to effectively convey its value proposition and growth strategy [6]. Portfolio Management and Growth Strategy - THC Therapeutics is focused on optimizing its portfolio by investing in high-potential opportunities and managing operations to maximize revenue [7][14]. - The company has acquired six companies under The Headquarters Group, Inc., diversifying its portfolio across various sectors of the cannabis industry [12]. - The strategy includes active portfolio management to capitalize on growth opportunities in the national cannabis market [14]. Future Outlook - The company expresses optimism about its future, emphasizing its commitment to creating long-term shareholder value through a differentiated and value-focused business model [11][9].

Core Insights - Greenway Greenhouse Cannabis Corporation reported significant financial growth in Q3 2025, with a 40% increase in net cannabis revenue year-over-year, reaching CAD 2,348,797 [1] - The company achieved its fifth consecutive quarter of positive adjusted EBITDA, amounting to CAD 399,738, reflecting improved operational efficiency and profitability [1] - Gross profit for the quarter was CAD 680,589, a substantial increase from CAD 249,197 in Q3 F2025, with gross margin improving to 29% from 15% [1] Financial Performance - Cash at the end of the quarter was CAD 1,181,770, with working capital (excluding amounts due to related parties) at CAD 5,819,285 [1] - Finished goods inventory was valued at CAD 3,377,433, totaling 3,053,665 grams, indicating strong support for anticipated customer demand [1] - The company reported a gross profit for the fiscal year 2026 totaling CAD 2,321,996, representing over a 350% increase compared to the previous year [1] Cost Management - Cash cost per gram sold decreased to CAD 0.92 from CAD 1.03 in Q3 F2025, demonstrating effective cost management strategies [1] - The company emphasized disciplined execution in production to drive durable results and improve unit economics [1] Strategic Outlook - The CEO highlighted the company's objective to build a resilient, high-quality cannabis platform capable of generating consistent returns through industry cycles [1] - The focus remains on scaling production efficiently, optimizing yields, and enhancing product mix to maintain momentum [1] Share Issuance - Greenway issued 402,549 common shares to a consultant as part of a corporate-finance advisory service agreement, with prices ranging from CAD 0.15 to CAD 0.25 per share [1]

Core Insights - iAnthus Capital Holdings, Inc. is making significant progress in retail expansion, brand development, and capital structure initiatives in the cannabis industry [1] Retail Expansion - The Company plans to open its 26th GrowHealthy dispensary in Tequesta, Florida, on or about March 27, 2026, pending regulatory approvals, to enhance patient access in Palm Beach County [2] - The Tequesta dispensary aims to provide convenient access to high-quality cannabis products and is designed to meet the diverse wellness needs of the local community [3][4] Brand Development - In New Jersey, iAnthus has expanded its brand, The Vault, which features a curated archive of cannabis genetics aimed at resonating with distinct consumer segments [5] Capital Structure Initiatives - iAnthus, along with its subsidiary iAnthus New Jersey, LLC, has entered into amending agreements with related-party lenders to amend the terms of senior secured bridge notes issued on February 2, 2021 [6] - The maturity date of the Bridge Notes has been extended from February 16, 2026, to June 24, 2027, with an amendment fee of 2% of the principal amount, which is approximately US$8.4 million as of February 16, 2026 [7][8]

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting As filed with the Securities and Exchange Commission on January 26, 2026 Washington, D.C. 20549 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Akanda Corp. c/o Gowling WLG (Canada) LLP 100 King St. W, Suite 1600 Toronto, ON M5X 1G5, Canada Tel: +1 (4 ...

Summary of NewLake Capital Partners Conference Call Company Overview - **Company**: NewLake Capital Partners (OTCPK:NLCP) - **Type**: Net lease REIT focused exclusively on the cannabis industry - **Founded**: Nearly seven years ago - **Investment**: Deployed almost $500 million into the cannabis sector - **Portfolio**: Owns 34 properties across 12 states with 13 different tenants - **Weighted Average Yield**: 13% [4][5] Financial Position - **Leverage**: Nearly unlevered with only $7 million in credit facility debt - **Cash Position**: Net cash position, unusual for a REIT - **Average Lease Term**: Over 12 years remaining [5] - **Dividend Growth**: Nearly 80% growth since IPO in 2021, consistent dividend of $0.43 per share [5][20] Industry Insights - **Cannabis Market Size**: Estimated to be around $34-$35 billion in 2025 for the state-legal industry; overall cannabis industry (including illicit market) believed to exceed $100 billion [7][9] - **Growth Drivers**: Transition of medical states to adult-use markets, evolving medical programs, and changing consumer preferences, particularly among younger cohorts [8][10] - **Legislative Changes**: Potential rescheduling of cannabis from Schedule I to Schedule III, which would eliminate onerous tax consequences (IRS 280E) and enhance cash flow for operators [11][12] Portfolio Strategy - **Focus on Limited License States**: Targeting states with limited licenses to enhance margins and credit quality [16][17] - **Tenant Quality**: Emphasis on understanding tenant financials and management quality, with a focus on their ability to raise capital [15] - **Top Tenants**: Includes leading companies like Curaleaf, Cresco Labs, and Trulieve, which represent over 50% of the portfolio [19][20] Market Dynamics - **State-Level Growth**: States like Texas and Kentucky are expected to see significant growth in medical marijuana programs, requiring substantial real estate investment [35][36] - **Federal Regulation Impact**: Anticipated changes in federal regulations could lead to increased competition from traditional banks, but NewLake believes its niche focus will protect its market position [31][33] Risk Management - **Tenant Health**: Monitoring tenant performance closely; recent issues with Ayr Wellness led to property turnover, but proactive measures are in place for re-tenanting [25][26] - **Payout Ratio**: Maintains an 82% payout ratio, allowing for absorption of potential vacancies without impacting dividends [22][23] Competitive Landscape - **Comparison with Peers**: NewLake differentiates itself from larger peers like Innovative Industrial Properties by focusing on limited license states and property-level cash flows, which has resulted in better tenant retention [40][41] Future Outlook - **Capital Allocation**: Strong balance sheet allows for continued investment without the need for equity dilution; share buybacks are considered when advantageous [38][39] - **Market Opportunities**: Significant room for growth in the cannabis sector, particularly as more states adopt adult-use legislation and the federal government regulates the market [37] This summary encapsulates the key points discussed during the NewLake Capital Partners conference call, highlighting the company's strategic focus, financial health, industry dynamics, and future growth potential.